RHUMBLINE ADVISERS - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$318,877
-23.5%
91,898
+2.5%
0.00%
Q2 2023$416,863
+106514.6%
89,648
+5.8%
0.00%
Q1 2023$391
-37.7%
84,696
+8.9%
0.00%
-100.0%
Q4 2022$628
-99.8%
77,771
+9.6%
0.00%0.0%
Q3 2022$394,000
+20.5%
70,984
+13.1%
0.00%
Q2 2022$327,000
-28.0%
62,756
+13.7%
0.00%
-100.0%
Q1 2022$454,000
-45.5%
55,176
-1.4%
0.00%0.0%
Q4 2021$833,000
-20.1%
55,973
+1.3%
0.00%0.0%
Q3 2021$1,043,000
+5.5%
55,236
+3.8%
0.00%0.0%
Q2 2021$989,000
+48.5%
53,211
+81.9%
0.00%0.0%
Q1 2021$666,000
+10.6%
29,251
+5.6%
0.00%0.0%
Q4 2020$602,000
+192.2%
27,711
+35.1%
0.00%
Q3 2020$206,000
+41.1%
20,510
+9.3%
0.00%
Q2 2020$146,000
+3.5%
18,773
+36.1%
0.00%
Q1 2020$141,000
-7.2%
13,7980.0%0.00%
Q4 2019$152,000
+23.6%
13,798
+1.6%
0.00%
Q3 2019$123,000
-12.8%
13,578
+9.3%
0.00%
Q2 2019$141,00012,4220.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders